Home

OS Therapies Incorporated Common Stock (OSTX)

1.8100
+0.0500 (2.84%)
NYSE · Last Trade: Jun 27th, 12:09 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Which stocks are gapping on Monday?chartmill.com
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · April 28, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · March 20, 2025
Friday's session: gap up and gap down stockschartmill.com
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · February 14, 2025
Top movers in Friday's pre-market sessionchartmill.com
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 14, 2025
OSTX Stock Earnings: OS Therapies Reported Results for Q2 2024investorplace.com
OS Therapies just reported results for the second quarter of 2024.
Via InvestorPlace · August 25, 2024
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancerbenzinga.com
OS Therapies advances OST-HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.
Via Benzinga · February 14, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 31, 2025
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Whystocktwits.com
Cancer treatments, FDA breakthroughs, and other developments fueled a sharp spike in interest for these biotech players, as investors bet on promising clinical data and strategic moves.
Via Stocktwits · January 21, 2025
Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday?benzinga.com
OS Therapies shares Phase 2b trial results showing OST-HER2 improves survival rates in rare metastatic osteosarcoma, surpassing historical controls.
Via Benzinga · January 15, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · October 3, 2024
Transforming Cancer Therapy Stocks to Watch In The Oncology Sector
Transforming Cancer Therapy Stocks to Watch In The Oncology Sector
Via News Direct · September 12, 2024
Transforming Oncology: Stocks to Watch in the Oncology Sector
Transforming Oncology: Stocks to Watch in the Oncology Sector
Via News Direct · September 12, 2024
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · August 19, 2024
OS Therapies Falls Following Downsized IPOtalkmarkets.com
Shares of OS Therapies fell on Thursday following a downsized initial public offering by the oncology drug developer in a slow week for the IPO market.
Via Talk Markets · August 4, 2024
Dow Dips Over 400 Points; Apple Posts Upbeat Earningsbenzinga.com
Via Benzinga · August 2, 2024
Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · August 2, 2024